
Old drugs, new tricks? A novel immunomodulatory approach to relapsed osteosarcoma therapy
MIB Agents OsteoBites ›1:01:31 | Jul 11th
Kelly Faulk, MD, a pediatric oncologist at Children's Hospital Colorado Center for Cancer and Blood Disorders, joins us on OsteoBites to review the open phase 1/1b clinical trial evaluating the combin...Show More
Recommendations